Healthtech funding in H2 2014

European Healthtech startup funding raised during H2 2014.

In H2 2014, 62 European Healthtech companies closed 64 funding rounds and raised €542M in equity funding (excluding debt and grants), up 64.9% versus H2 2013. UK led by capital raised, and Wellington Partners was the most active investor. Data as of 6 Nov 2026.

Equity funding

€542M

+64.9% vs H2 2013 · excl. debt & grants

Funding rounds

+3.2% vs H2 2013

Companies

Top country

Rank among sectors

7.5% of sector funding

Top-10 round share

70.1%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Jul	€18M	7
Aug	€58M	9
Sep	€170M	12
Oct	€40M	9
Nov	€129M	12
Dec	€128M	15

Top countries

by € raised

Data table

	Healthtech — top countries by capital, H2 2014
UK	€198M
Switzerland	€114M
Israel	€69M
Denmark	€51M
Netherlands	€41M
Germany	€33M
France	€18M
Finland	€15M

Stage mix

by € raised

Data table

	Healthtech — stage mix, H2 2014
Series B	€148M
Series A	€126M
Series D+	€77M
Other	€58M
Series C	€48M
Growth/Late	€39M
Early VC	€34M
Seed	€12M
Grant	€1.5M

Exits & M&A

2 Acquisition

2 exits · €16M disclosed.

GenKyoTex

Acquisition

Nov 2014

€16M

Top deals

largest disclosed rounds in H2 2014

Company	Stage	Date	Amount
Adaptimmune	Series A	Sep 2014	€79M
Biocartis	Series D+	Sep 2014	€65M
Cell Medica	Series B	Nov 2014	€64M
Ascendis Pharma	Series C	Dec 2014	€48M
Quanta Fluid Solutions	Series B	Nov 2014	€34M
Xeltis	Series B	Dec 2014	€27M
Gamida Cell	Growth/Late	Aug 2014	€26M
MagForce	Other	Aug 2014	€14M
AM-Pharma	Series D+	Sep 2014	€12M
Anergis	Series B	Dec 2014	€12M
NeuroDerm	Growth/Late	Aug 2014	€12M
GI View	Other	Dec 2014	€10M
Sophia Genetics	Series B	Jul 2014	€10M
Check-Cap	Other	Oct 2014	€9.5M
Rigontec	Series A	Oct 2014	€9.4M

View all 64 Healthtech deals in H2 2014 →

Top investors

most active in H2 2014, by deal count

← All 2014 Healthtech funding